72
Participants
Start Date
January 22, 2014
Primary Completion Date
October 25, 2019
Study Completion Date
January 10, 2024
Biopsy
Undergo image-guided biopsy
Computed Tomography
Undergo 18F-DOPA-PET/CT
Diffusion Weighted Imaging
Undergo DTI
Fluorine F 18 Fluorodopa
Undergo 18F-DOPA-PET/CT
Laboratory Biomarker Analysis
Correlative studies
Perfusion Magnetic Resonance Imaging
Undergo pMRI
Positron Emission Tomography
Undergo 18F-DOPA-PET/CT
Therapeutic Conventional Surgery
Undergo stereotactic craniotomy
Mayo Clinic, Rochester
Lead Sponsor
National Cancer Institute (NCI)
NIH
Mayo Clinic
OTHER